143 related articles for article (PubMed ID: 2979736)
1. Metabolism of [14C]MPTP in mouse and monkey implicates MPP+, and not bound metabolites, as the operative neurotoxin.
Yang SC; Johannessen JN; Markey SP
Chem Res Toxicol; 1988; 1(4):228-33. PubMed ID: 2979736
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G
Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986
[TBL] [Abstract][Full Text] [Related]
3. Uptake of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and the N-methyl-4-phenylpyridinium ion (MPP+) into fetal mouse brain through the placenta.
Ohya Y; Naoi M; Ochi N; Mizutani N; Watanabe K; Nagatsu T
Neurosci Lett; 1989 Oct; 105(1-2):221-6. PubMed ID: 2485882
[TBL] [Abstract][Full Text] [Related]
4. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons.
Johannessen JN
Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587
[TBL] [Abstract][Full Text] [Related]
5. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
Mitsumoto Y; Mori A
Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
[TBL] [Abstract][Full Text] [Related]
6. Biochemical evaluation of the neurotoxicity of MPTP and MPP⁺ in embryonic and newborn mice.
Sai T; Uchida K; Nakayama H
J Toxicol Sci; 2013; 38(3):445-58. PubMed ID: 23665943
[TBL] [Abstract][Full Text] [Related]
7. Acetaldehyde directly enhances MPP+ neurotoxicity and delays its elimination from the striatum.
Zuddas A; Corsini GU; Schinelli S; Barker JL; Kopin IJ; di Porzio U
Brain Res; 1989 Oct; 501(1):11-22. PubMed ID: 2804689
[TBL] [Abstract][Full Text] [Related]
8. Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice.
Vaglini F; Fascetti F; Tedeschi D; Cavalletti M; Fornai F; Corsini GU
Neurodegeneration; 1996 Jun; 5(2):129-36. PubMed ID: 8819133
[TBL] [Abstract][Full Text] [Related]
9. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
Zuddas A; Fascetti F; Corsini GU; Piccardi MP
Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
[TBL] [Abstract][Full Text] [Related]
10. Tissue concentrations of MPTP and MPP+ after administration of lethal and sublethal doses of MPTP to mice.
Fuller RW; Hemrick-Luecke SK
Toxicol Lett; 1990 Dec; 54(2-3):253-62. PubMed ID: 2124381
[TBL] [Abstract][Full Text] [Related]
11. Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.
Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
J Pharmacol Exp Ther; 1991 May; 257(2):691-7. PubMed ID: 2033514
[TBL] [Abstract][Full Text] [Related]
12. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity.
Nwanze E; Souverbie F; Jonsson G; Sundström E
Neurotoxicology; 1995; 16(3):469-77. PubMed ID: 8584278
[TBL] [Abstract][Full Text] [Related]
13. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells.
Fang J; Zuo D; Yu PH
Psychopharmacology (Berl); 1995 Oct; 121(3):373-8. PubMed ID: 8584620
[TBL] [Abstract][Full Text] [Related]
15. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
Riachi NJ; Harik SI; Kalaria RN; Sayre LM
J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
[TBL] [Abstract][Full Text] [Related]
16. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
Irwin I; Langston JW
Life Sci; 1985 Jan; 36(3):207-12. PubMed ID: 3871240
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
Fuller RW; Hemrick-Luecke SK; Robertson DW
Biochem Pharmacol; 1988 Sep; 37(17):3343-7. PubMed ID: 3135812
[TBL] [Abstract][Full Text] [Related]
19. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
20. Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Staal RG; Yang JM; Hait WN; Sonsalla PK
Brain Res; 2001 Aug; 910(1-2):116-25. PubMed ID: 11489261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
